Lung cancer secondary prevention: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Lung cancer}} | {{Lung cancer}} | ||
{{CMG}} {{AE}} Saarah T. Alkhairy, M.D. | |||
==Overview== | |||
Secondary prevention for lung cancer consists of smoking cessation and screening. Secondary chemoprevention focuses on blocking the development of lung cancer in individuals in whom a precancerous lesion has been detected. | |||
==Lung Cancer Secondary Prevention== | |||
Secondary prevention for lung cancer consists of smoking cessation and screening. | |||
To view the screening of lung cancer, click [[Lung cancer screening|'''here''']] | |||
Secondary chemoprevention focuses on blocking the development of lung cancer in individuals in whom a precancerous lesion has been detected. It still remains experimental. | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
[[Category:Disease]] | |||
[[Category: | [[Category:Types of cancer]] | ||
[[Category:Pulmonology]] | |||
[[Category:Lung cancer]] | |||
[[Category:Oncology]] | |||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
Revision as of 15:41, 22 July 2015
|
Lung cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Lung cancer secondary prevention On the Web |
|
American Roentgen Ray Society Images of Lung cancer secondary prevention |
|
Risk calculators and risk factors for Lung cancer secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Saarah T. Alkhairy, M.D.
Overview
Secondary prevention for lung cancer consists of smoking cessation and screening. Secondary chemoprevention focuses on blocking the development of lung cancer in individuals in whom a precancerous lesion has been detected.
Lung Cancer Secondary Prevention
Secondary prevention for lung cancer consists of smoking cessation and screening.
To view the screening of lung cancer, click here
Secondary chemoprevention focuses on blocking the development of lung cancer in individuals in whom a precancerous lesion has been detected. It still remains experimental.